SAFC Commercial, the custom manufacturing services business unit of Sigma-Aldrich Corp., is expanding two of its manufacturing facilities in the U.S. to support the manufacture of targeted and cytotoxic therapies. SAFC is investing in commercial-scale manufacturing capacity for antibody drug conjugates (ADCs) in St. Louis, MO, and expanding its high-potency active pharmaceutical ingredient (HPAPI) manufacturing and storage at the Verona facility near Madison, WI.   The ADC expansion is expected ...